Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > news release

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Oct 07, 2024 3:02pm

241 Views

Post# 36256590

RE:RE:RE:RE:RE:RE:news release

I'm surprised there still seems to be so much confusion over the timetable and differences between a pre-BTD submission, when the FDA is expected to respond to that, a submission for BTD, and when the FDA is expected to respond to that.... especially from a few of you that have followed TLT (and posted comments here) for as long as you have.

If you don't figure it out (and real soon,) I have little doubt that the market will eventually (at the appropriate time) que you in as to what is (and isn't) important.. lol.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant